Sodium–glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results